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The Seveso accident in 1976 caused a large, populated area north of Milan, Italy, to be contaminated by 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD). In this study, the authors followed up the exposed population for chronic
effects; this paper reports the results of the mortality follow-up extension for 1997–2001. The study cohort includes
278,108 subjects resident at the time of the accident or immigrating/born in the 10 years thereafter in three
contaminated zones with decreasing TCDD soil levels (zone A, very high; zone B, high; zone R, low) and in
a reference territory comprising surrounding, noncontaminated municipalities. Vital status and cause-of-death
ascertainment were 99% complete. Adjusted rate ratios and 95% conﬁdence intervals were calculated by using
Poisson regression. Results conﬁrmed previous ﬁndings of excesses of lymphatic and hematopoietic tissue neo-
plasms in zones A (six deaths; rate ratio¼ 2.23, 95% conﬁdence interval: 1.00, 4.97) and B (28 deaths; rate ratio¼
1.59, 95% conﬁdence interval: 1.09, 2.33). These zones also showed increased mortality from circulatory diseases
in the ﬁrst years after the accident, from chronic obstructive pulmonary disease, and from diabetes mellitus among
females. A toxic and carcinogenic risk to humans after high TCDD exposure is supported by the results of this
study.
accidents, occupational; carcinogens, environmental; chemical industry; cohort studies; mortality;
tetrachlorodibenzodioxin
Abbreviations: CI, conﬁdence interval; RR, rate ratio; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin.
The most toxic member of the large family of poly-
chlorodibenzodioxins is 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD), a nonwanted by-product of numerous chemical re-
actions involving chlorine compounds, highly persistent in
the environment and biologic organisms, that was recognized
as a strong toxicant and carcinogen in experimental animals
(1–4). In humans, the epidemiologic evidence for carcinoge-
nicity was considered ‘‘limited’’ by an international expert
group in 1997, yet mechanistic considerations led to its clas-
sification as a ‘‘human carcinogen’’ (3). This evaluation was
supported by most subsequent studies involving military
(5–8), occupational (9–12), and population cohorts (13–
15); reanalyses with estimates of the dose-response relation
(16–19); and meta-analyses and reviews (20, 21). Questions
about the epidemiologic evidence and debate on the actual
cancer risk posed by TCDD to the general population remain
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(22–25). Other health effects reported to be associated with
TCDD exposure include diabetes mellitus, circulatory dis-
eases, and pulmonary disease (3).
The Seveso, Italy, dioxin episode caused severe TCDD
exposure to a population comprising people of both genders
and all ages, with little or no interference by other contam-
inants. The accident took place on July 10, 1976, in the
trichlorophenol production department of a chemical plant
located near the town of Seveso, 25 km north of Milan.
A chemical cloud containing several kilograms of TCDD
was released into the environment and contaminated a vast
and densely populated area (26, 27).
Several health outcomes were investigated in the early post-
accident period, including spontaneous abortion (28), cytoge-
netic abnormalities (29, 30), congenital malformations (31,
32), liver function and lipid metabolism (33, 34), immuno-
logic (35) and neurologic (36, 37) impairment, and chloracne
(38). In 1984, the government-appointed International Steer-
ing Committee concluded that the only ascertained health
effect was chloracne, occurring mainly in children (39).
In 1985, we implemented a cohort study to investigate the
long-term impact of the accident on mortality and cancer in-
cidence. We recorded elevated cardiovascular mortality in the
first years after the event and suggestive increases in diabetes
and chronic lung diseases. The most consistent finding was an
elevated risk of lymphatic and hematopoietic neoplasm among
both males and females (13, 14). We report here the results of
the mortality follow-up extension for the period 1997–2001.
MATERIALS AND METHODS
Methods for cohort identification, exposure definition,
follow-up, and cause-of-death ascertainment were previ-
ously described in detail (13, 40) and are summarized here.
Subjects
The contaminated area was divided into three zones,
namely, A (very high contamination, from where people
were displaced), B (high), and R (low) (figure 1). The study
population (table 1) included two components: the first of
more than 37,000 subjects residing in any of the three con-
tamination zones on the day of the accident (‘‘present’’) who
were directly exposed to the toxic cloud and may have con-
sumed food from local crops and animals; and the second of
about 8,000 persons who migrated into (or were newborn in)
any of the contaminated zones in the 10-year period after
the accident (‘‘nonpresent’’). The A, B, and R zones encom-
passed portions of the territory of six municipalities. As a ref-
erence population, we elected the residents of the unaffected
areas of those six plus those residents of five surrounding non-
contaminated towns (present: 181,574; nonpresent: 51,166).
The overall study cohort (exposed and nonexposed) thus
included 278,108 residents (79 percent residents at the time
of the accident) of 11 municipalities.
Exposure
Subjects were assigned to one of the zones (A, B, R, or
reference) based on their official residence on the day of the
accident or at entry into the area. Residence has the advan-
tage of being highly reliable and readily available for every
member of this large cohort; in the Lombardy region of
Italy, it is highly concordant with actual domicile (well over
95 percent). We also verified, in a small sample of cohort
members, that residence was highly concordant with actual
presence in the area on the day of the accident (41). Ana-
lytical constraints had precluded determination of biologic
exposure markers at that time. When analytical advance-
ments made it feasible to determine TCDD in small blood
samples taken shortly after the accident, elevated levels in-
dicating internal exposure to TCDD (and not to other dioxin-
like compounds) were documented in individuals living in
the contaminated zones (42, 43). High levels persisted in
blood and milk samples collected years later (41, 44, 45).
Importantly, the zone classification appeared in good agree-
ment with the average blood levels measured in several sam-
ples of the study population (table 2).
Living in the area after the accident seemed not to entail
additional exposure. None of zone B residents’ serum dioxin
levels increased over time, and no detectable serum TCDD
levels were found in a small sample of people who entered
the area after the accident (43), hence the stratification of the
cohort into the two components present and nonpresent.
Follow-up
The overall population (exposed and referents) has been
followed up as a single, unique cohort. The vital statistics
offices of the 11 study municipalities have been transmitting
whole population updates (births, deaths, migration within
and outside the area) without knowledge of exposure cate-
gorization. For those who emigrated outside the study area
and remained within the Lombardy region, we performed
a record linkage with population databases and traced about
40,000 subjects resident or dead elsewhere within the re-
gion. Finally, for those not linked or who did emigrate out-
side the region (about 20,000), we performed an individual
postal follow-up through the vital statistics offices of thou-
sands of municipalities throughout Italy.
Cause of death has been ascertained by record linkage
with databases of the National Central Statistics Institute
and Lombardy region local health units or by postal contact
with other vital statistics offices and local health units. In
case of successful linkage, we obtained the International
Classification of Diseases death codes. (The Eighth Revi-
sion was used for deaths before 1979 and the Ninth Revision
for deaths thereafter. All codes were then translated to Ninth
Revision codes.) When official codes were not available, the
underlying cause of death was coded by trained personnel
following standard rules blind to zone assignment. Epide-
miology units of some large cities collaborated in both vital
status and cause-of-death ascertainment.
Statistical analysis
We computed person-years of observation from begin-
ning of follow-up (July 10, 1976, or date of first entry) until
death or end of the study (December 31, 2001). We
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calculated cause-specific mortality rate ratios and their 95
percent confidence intervals for every contaminated zone
(A, B, and R) against the reference by using Poisson re-
gression models (46). The regression models were adjusted
for (or stratified by) the following covariates: presence at the
accident, gender, period (1976–1981, 1982–1986, 1987–1991,
FIGURE 1. The Seveso, Italy, area, including the territory of 11 towns. The map indicates the three dioxin-contaminated zones with decreasing
mean soil levels (A, B, and R) and the surrounding noncontaminated zone adopted as the reference.
TABLE 1. Number of subjects in the Seveso, Italy, cohort, 1976–2001, by zone of
residence* and presence in the area at the time of the dioxin accident
Zone
Present (resident of the
area on July 10, 1976)
Nonpresent (entered the
area after the accident) Total
Females Males Total Females Males Total
A 371 352 723 43 38 81 804
B 2,350 2,471 4,821 574 546 1,120 5,941
R 15,928 15,715 31,643 3,496 3,484 6,980 38,623
Reference 93,224 88,350 181,574 25,547 25,619 51,166 232,740
Total 111,873 106,888 218,761 29,660 29,687 59,347 278,108
* Refer to the Materials and Methods section of the text for a deﬁnition of these zones.
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1992–1996, and 1997–2001), age (<1, 1–4 years, then 5-year
categories until age 84 years, and85 years), and time since
first exposure (‘‘latency,’’ 0–4, 5–9, 10–14, 15–19, and 20
years).
We performed further analyses on selected subgroups of
the cohort including 182 persons with chloracne (47) and
about 3,000 residents in a zone R quarter named ‘‘Polo’’
with possible higher exposure than the surrounding zone R
(14). Final data management, person-year calculation, and
statistical analyses were performed by using Stata software,
version 9 (48).
RESULTS
Follow-up was more than 99 percent complete in each
zone. The total number of person-years at risk between
1976 and 2001 was more than 6 million (81 percent accrued
by subjects present at the accident), we recorded 47,584
deaths (93 percent present) (table 3), and exposed individ-
uals contributed 16.6 percent of the person-years and 15.2
percent of the deaths. There were some differences in the
source distribution of International Classification of Dis-
eases, Ninth Revision codes across zones: compared with
R and the reference zones, there were 5 percent fewer offi-
cial codes in zone B and 5 percent more in zone A, respec-
tively (table 4).
Tables 5 and 6 show results for subjects present at the
accident. During the whole study period, all-cause and all
cancer mortality in the three polluted zones was not elevated
in comparison with the reference population (table 5). The
most notable finding was increased mortality from cancers
of the lymphatic and hematopoietic tissues in the two most
polluted zones, with a significant (p ¼ 0.04) test for trend of
rate ratios across zones (A > B > R). The increases were
stronger for females (zone A: four deaths, rate ratio (RR) ¼
3.17, 95 percent confidence interval (CI): 1.18, 8.49; zone
B: 15 deaths, RR¼ 1.94, 95 percent CI: 1.16, 3.25), with the
TABLE 2. TCDD* soil levels and serum concentrations
measured in selected samples of residents in the study areay
after the 1976 Seveso, Italy, accident
Zone
Mean soil level
(lg/m2)z
Median lipid-adjusted
serum level in pg/g or
parts per trillion
Minimum–
maximum
Samples
collected
in 1976–
1977§ (no.)
Samples
collected
in 1992–
1996{ (no.)
A 15.5–580.4 447.0 (296) 73.3 (7)
B 1.7–4.3 94.0 (80) 12.4 (51)
R 0.9–1.4 48.0 (48) NA*
Reference NA NA 5.5 (52)
* TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; NA, not available.
yRefer to the Materials and Methods section of the text for
a deﬁnition of the study zones.
zRefer to Bertazzi and di Domenico (26) for more information.
§ Refer to Needham et al. (43) for more information.
{ Refer to Landi et al. (41) for more information.
TABLE 3. Person-years at risk and deaths in the Seveso, Italy,
cohort, 1976–2001, by zone of residence,* among subjects
resident (present) and not resident (nonpresent) in the area at
the time of the dioxin accident
Zone
Person-years Deaths
Present Nonpresent Present Nonpresent
A
No. 16,922 1,674 118 3
% 0.3 0.1 0.3 0.1
B
No. 113,724 22,837 750 61
% 2.3 1.9 1.7 1.8
R
No. 732,628 140,537 5,934 372
% 14.6 12.0 13.4 11.1
Reference
No. 4,153,763 1,010,778 37,428 2,918
% 82.8 86.0 84.6 87.0
Total
No. 5,017,038 1,175,826 44,230 3,354
% 100.0 100.0 100.0 100.0
* Refer to the Materials and Methods section of the text for
a deﬁnition of these zones.
TABLE 4. Source of ICD-9* codes for underlying cause of
death by zone of residencey in the Seveso, Italy, cohort, 1976–
2001
Zone
Central
Statistics
Institute
Local
health
units
Internal
coding
Missing Total
A
No. 61 14 46 0 121
% 50.4 11.6 38.0 0.0 100.0
B
No. 340 70 394 7 811
% 41.9 8.6 48.6 0.9 100.0
R
No. 2,806 700 2,728 72 6,306
% 44.5 11.1 43.3 1.1 100.0
Reference
No. 18,174 4,180 17,580 412 40,346
% 45.1 10.4 43.6 1.0 100.0
Total
No. 21,381 4,964 20,748 491 47,584
% 44.9 10.4 43.6 1.0 100.0
* ICD-9, International Classiﬁcation of Diseases, Ninth Revision.
yRefer to the Materials and Methods section of the text for
a deﬁnition of these zones.
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TABLE 5. Results of Poisson regression analyses of mortality in the Seveso, Italy, area, 1976–2001, for selected causes of death:
number of deaths, rate ratios, and 95% conﬁdence intervals for the polluted zones (A, B, and R) compared with the reference zone*,y
Cause of death (ICD-9z code)
Zone A Zone B Zone R
No. RRz 95% CIz No. RR 95% CI No. RR 95% CI
All causes (001–999) 118 1.02 0.85, 1.22 750 0.96 0.89, 1.03 5,934 1.03 1.01, 1.06
All cancers (140–208) 42 1.03 0.76, 1.39 244 0.92 0.81, 1.05 1,848 0.97 0.92, 1.02
Digestive (150–159) 15 0.95 0.57, 1.57 81 0.78 0.63, 0.97 718 0.95 0.88, 1.03
Stomach (151) 3 0.65 0.21, 2.03 24 0.78 0.52, 1.17 212 0.95 0.82, 1.09
Colon (153) 3 0.98 0.31, 3.03 12 0.60 0.34, 1.06 137 0.94 0.78, 1.12
Rectum (154) 1 0.90 0.13, 6.42 11 1.51 0.83, 2.76 50 0.94 0.70, 1.27
Liver (155) 3 1.03 0.33, 3.20 16 0.86 0.52, 1.40 107 0.80 0.65, 0.98
Biliary tract (156) 0 0 2 0.56 0.14, 2.26 31 1.16 0.79, 1.70
Pancreas (157) 2 1.17 0.29, 4.68 5 0.45 0.19, 1.09 76 0.95 0.74, 1.21
Other digestive (159) 2 2.43 0.60, 9.76 8 1.49 0.74, 3.01 38 0.95 0.67, 1.33
Respiratory (160–165) 11 1.11 0.62, 2.01 70 1.10 0.87, 1.40 432 0.97 0.88, 1.07
Lung (162) 11 1.26 0.70, 2.29 62 1.11 0.87, 1.43 383 0.98 0.88, 1.09
Soft tissue sarcoma (171) 0 0 0 0 4 0.76 0.27, 2.14
Melanoma (172) 1 3.06 0.43, 22.01 2 0.97 0.24, 3.93 12 0.83 0.45, 1.51
Breast (174) 2 0.60 0.15, 2.41 13 0.65 0.37, 1.12 133 0.87 0.73, 1.05
Genitourinary tract (179–189) 3 0.62 0.20, 1.94 28 0.89 0.61, 1.29 240 1.04 0.91, 1.20
Uterus (179–182) 0 0 2 0.48 0.12, 1.92 41 1.26 0.90, 1.75
Ovary (183) 1 1.19 0.17, 8.46 2 0.39 0.10, 1.57 37 0.96 0.68, 1.36
Prostate (185) 1 0.87 0.12, 6.17 8 0.88 0.44, 1.77 65 1.06 0.81, 1.38
Bladder (188) 1 1.04 0.15, 7.39 6 0.90 0.40, 2.01 42 0.88 0.64, 1.22
Kidney (189) 0 0 3 0.63 0.20, 1.98 39 1.15 0.82, 1.62
Brain (191) 0 0 3 0.67 0.22, 2.11 34 1.10 0.76, 1.58
Lymphatic and hematopoietic tissue (200–208) 6 2.23 1.00, 4.97 28 1.59 1.09, 2.33 124 0.99 0.82, 1.20
Hodgkin’s disease (201) 0 0 3 2.15 0.67, 6.86 9 0.94 0.46, 1.89
Non-Hodgkin’s lymphoma (200, 202) 3 3.35 1.07, 10.46 7 1.23 0.58, 2.60 40 0.99 0.71, 1.38
Multiple myeloma (203) 2 4.34 1.07, 17.52 5 1.68 0.69, 4.10 24 1.10 0.71, 1.69
Leukemia (204–208) 1 0.89 0.12, 6.31 13 1.73 1.00, 3.02 51 0.96 0.72, 1.29
Lymphatic leukemia (204) 0 0 3 1.30 0.41, 4.10 23 1.41 0.90, 2.21
Myeloid leukemia (205) 1 2.12 0.30, 15.17 6 1.97 0.87, 4.46 16 0.74 0.44, 1.24
Leukemia, unspeciﬁed (208) 0 0 4 2.38 0.87, 6.52 10 0.84 0.43, 1.62
Diabetes mellitus (250) 3 1.01 0.33, 3.14 26 1.32 0.89, 1.94 192 1.26 1.08, 1.47
All circulatory diseases (390–459) 45 1.06 0.79, 1.42 289 0.99 0.88, 1.11 2,357 1.07 1.02, 1.12
Chronic rheumatic heart disease (393–398) 3 5.74 1.83, 17.99 1 0.30 0.04, 2.18 24 0.99 0.64, 1.52
Hypertension (400–405) 5 2.18 0.90, 5.25 11 0.72 0.40, 1.31 144 1.20 1.01, 1.43
Ischemic heart disease (410–414) 13 0.83 0.48, 1.43 102 0.95 0.78, 1.15 842 1.06 0.98, 1.14
Myocardial infarction (410) 6 0.63 0.28, 1.41 54 0.86 0.65, 1.12 447 0.98 0.89, 1.08
Chronic ischemic heart disease (412, 414) 7 1.11 0.53, 2.34 47 1.06 0.80, 1.42 390 1.16 1.04, 1.29
Cerebrovascular disease (430–438) 11 0.90 0.50, 1.63 101 1.21 0.99, 1.48 695 1.09 1.00, 1.18
Respiratory disease (460–519) 9 1.41 0.73, 2.71 48 1.03 0.77, 1.36 341 0.99 0.89, 1.11
Chronic obstructive pulmonary disease (490–493) 7 2.53 1.20, 5.32 26 1.26 0.85, 1.86 175 1.17 1.00, 1.38
Digestive disease (520–579) 5 0.72 0.30, 1.74 45 0.99 0.74, 1.33 366 1.11 1.00, 1.24
Cirrhosis of the liver (571) 2 0.46 0.11, 1.83 23 0.82 0.54, 1.24 217 1.09 0.94, 1.26
Unknown (799.9) 0 0 7 0.85 0.40, 1.79 60 1.06 0.80, 1.39
Accidents (800–999) 7 1.09 0.52, 2.30 46 1.03 0.77, 1.39 299 1.00 0.88, 1.13
* Refer to the Materials and Methods section of the text for a deﬁnition of these zones.
y Included were all ages of subjects, both genders, and resident in the Seveso area at the time of the accident.
z ICD-9, International Classiﬁcation of Diseases, Ninth Revision; RR, rate ratio adjusted for gender, age, and period; CI, conﬁdence interval.
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TABLE 6. Results of Poisson regression analyses of mortality in the Seveso, Italy, area,
1976–2001, for selected causes of death, by time since the dioxin accident: number of
deaths, rate ratios, and 95% conﬁdence intervals for the polluted zones (A, B, and R)
compared with the reference zone*,y
Cause of death and zone
No. of years since the accident
0–4 5–9 10–14 15–19 20
All cancers
Zone A
No. 4 8 4 8 18
RRz 0.65 1.17 0.50 0.88 1.65
95% CIz 0.24, 1.74 0.58, 2.34 0.19, 1.33 0.44, 1.77 1.04, 2.62
Zone B
No. 30 52 59 64 39
RR 0.75 1.12 1.11 1.11 0.58
95% CI 0.53, 1.08 0.85, 1.47 0.86, 1.44 0.87, 1.42 0.42, 0.79
Zone R
No. 271 315 358 402 502
RR 0.90 0.92 0.94 0.98 1.08
95% CI 0.80, 1.03 0.82, 1.03 0.84, 1.05 0.88, 1.08 0.98, 1.18
Lung cancer
Zone A
No. 1 2 1 3 4
RR 0.78 1.51 0.53 1.62 1.66
95% CI 0.11, 5.57 0.38, 6.06 0.07, 3.75 0.52, 5.04 0.62, 4.44
Zone B
No. 8 13 13 14 14
RR 0.95 1.44 1.08 1.21 0.95
95% CI 0.47, 1.91 0.83, 2.50 0.62, 1.87 0.71, 2.06 0.56, 1.62
Zone R
No. 47 55 90 88 103
RR 0.77 0.86 1.06 1.09 1.03
95% CI 0.57, 1.04 0.65, 1.14 0.85, 1.32 0.87, 1.37 0.84, 1.27
Lymphatic and
hematopoietic
tissue cancer
Zone A
No. 0 0 0 2 4
RR 0 0 0 3.30 5.38
95% CI 0.82, 13.31 2.00, 14.49
Zone B
No. 4 5 8 7 4
RR 1.40 1.70 2.44 1.82 0.86
95% CI 0.52, 3.78 0.70, 4.15 1.20, 4.98 0.85, 3.86 0.32, 2.31
Zone R
No. 12 17 27 33 35
RR 0.58 0.80 1.15 1.21 1.09
95% CI 0.32, 1.05 0.48, 1.32 0.76, 1.74 0.83, 1.75 0.76, 1.56
Table continues
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TABLE 6. Continued
Cause of death and zone
No. of years since the accident
0–4 5–9 10–14 15–19 20
Diabetes mellitus
Zone A
No. 0 1 1 0 1
RR 0 1.84 1.63 0 1.61
95% CI 0.26, 13.09 0.23, 11.65 0.23, 11.51
Zone B
No. 7 2 7 8 2
RR 2.42 0.51 1.66 1.67 0.51
95% CI 1.14, 5.17 0.13, 2.05 0.78, 3.51 0.83, 3.38 0.13, 2.06
Zone R
No. 26 33 49 49 35
RR 1.10 1.06 1.49 1.33 1.24
95% CI 0.73, 1.67 0.74, 1.53 1.10, 2.04 0.98, 1.81 0.86, 1.78
All circulatory
diseases
Zone A
No. 12 14 5 5 9
RR 1.36 1.84 0.67 0.59 0.88
95% CI 0.77, 2.40 1.09, 3.12 0.28, 1.60 0.24, 1.42 0.46, 1.69
Zone B
No. 55 64 43 51 76
RR 0.96 1.10 0.79 0.87 1.18
95% CI 0.73, 1.25 0.86, 1.41 0.59, 1.07 0.66, 1.15 0.94, 1.48
Zone R
No. 527 471 455 409 495
RR 1.14 1.06 1.14 0.95 1.07
95% CI 1.04, 1.25 0.96, 1.17 1.03, 1.26 0.85, 1.05 0.97, 1.18
Chronic obstructive
pulmonary
disease
Zone A
No. 4 0 0 3 0
RR 7.23 0 0 5.43 0
95% CI 2.69, 19.48 1.74, 17.01
Zone B
No. 3 8 5 5 5
RR 0.79 2.27 1.15 1.19 1.04
95% CI 0.25, 2.47 1.12, 4.62 0.47, 2.79 0.49, 2.90 0.43, 2.53
Zone R
No. 27 36 38 33 41
RR 0.93 1.40 1.25 1.09 1.24
95% CI 0.62, 1.39 0.98, 2.00 0.88, 1.76 0.75, 1.57 0.89, 1.74
* Refer to the Materials and Methods section of the text for a deﬁnition of these zones.
y Included were all ages of subjects, both genders, and resident in the Seveso area at the time
of the accident.
zRR, rate ratio adjusted for gender and age; CI, conﬁdence interval.
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highest risks for non-Hodgkin’s lymphomas (zone A: two
deaths, RR ¼ 4.45, 95 percent CI: 1.10, 17.99), all lympho-
mas (zone B: seven deaths, RR ¼ 2.14, 95 percent CI: 1.00,
4.57), and myelomas (zone B: four deaths, RR ¼ 3.07, 95
percent CI: 1.12, 8.42). Among males, only leukemia deaths
in zone B were significantly above expectation (nine deaths,
RR ¼ 2.07, 95 percent CI: 1.06, 4.05). No deaths from soft-
tissue sarcomas were observed in zones A and B, and mor-
tality from this cancer in zone R was below the reference.
In zone A, liver cancer was not elevated, whereas lung
cancer showed a 26 percent increase; for both cancers, all
deaths occurred among males, yielding increased rate ratios
of 1.45 (95 percent CI: 0.47, 4.51) and 1.45 (95 percent CI:
0.80, 2.62), respectively. All circulatory diseases were not
elevated. The chronic rheumatic heart diseases and hyper-
tension increases were confined to females: among them,
three deaths from chronic rheumatic heart diseases and four
from hypertension yielded rate ratios of 9.19 (95 percent CI:
2.91, 29.01) and 2.60 (95 percent CI: 0.97, 6.95), respec-
tively. Males showed elevated mortality from circulatory
diseases (29 deaths, RR ¼ 1.40, 95 percent CI: 0.97, 2.01)
and chronic ischemic heart diseases (seven deaths, RR ¼
2.48, 95 percent CI: 1.18, 5.22). Chronic obstructive pulmo-
nary disease was more than doubled; the risk was elevated
for both genders, but there were very few deaths among
females (males: five deaths, RR ¼ 2.72, 95 percent CI:
1.13, 6.57; females: two deaths, RR ¼ 2.07, 95 percent
CI: 0.52, 8.33). There were only three noncancer deaths
among subjects who entered zone A after the accident
(RR ¼ 1.01, 95 percent CI: 0.33, 3.14).
In zone B, there was a 50 percent nonsignificant increase
in rectal and other digestive cancer mortality; the excesses
were limited to males, with, respectively, eight deaths (RR¼
1.81, 95 percent CI: 0.89, 3.67) and six deaths (RR ¼
2.52, 95 percent CI: 1.10, 5.74). Cerebrovascular diseases
showed a moderate increase among both males (51 deaths,
RR ¼ 1.24, 95 percent CI: 0.94, 1.64) and females (50
deaths, RR ¼ 1.19, 95 percent CI: 0.90, 1.58). Among fe-
males, we observed elevated rates of diabetes mellitus (20
deaths, RR ¼ 1.78, 95 percent CI: 1.14, 2.77), chronic ob-
structive pulmonary disease (11 deaths, RR ¼ 1.99, 95 per-
cent CI: 1.09, 3.64), and digestive diseases (23 deaths, RR¼
1.42, 95 percent CI: 0.94, 2.14). We recorded 17 cancer
deaths among subjects nonpresent at the accident (RR ¼
1.60, 95 percent CI: 0.99, 2.59); six deaths were digestive
cancers (RR¼ 1.88, 95 percent CI: 0.83, 4.22) and two were
lymphatic and hematopoietic cancers (RR ¼ 1.74, 95 per-
cent CI: 0.43, 7.12); among noncancer causes, only acci-
dents showed an increased rate (nine deaths, RR ¼ 1.94, 95
percent CI: 1.00, 3.78).
In zone R, there was a 20 percent reduction in liver cancer
mortality compared with the rates in the reference zone. We
also observed modest increases in the rates of diabetes mel-
litus and several circulatory diseases, which, with the ex-
ception of cerebrovascular diseases, were limited to females
(1,246 deaths from all circulatory diseases, RR ¼ 1.09, 95
percent CI: 1.03, 1.16). Among people nonresident at the
time of the accident, we did not observe meaningful in-
creased (or decreased) rates of cancer and noncancer causes
of death.
Table 6 shows results of the analyses by time since the
accident (‘‘latency’’) for causes selected because they were
found in excess in this or in previous relevant epidemiologic
studies. All cancer mortality showed a 65 percent increase
after 20 years in zone A from lung (four deaths), digestive
(six deaths, including three liver cancers that yielded an RR
of 3.74, 95 percent CI: 1.20, 11.71), and lymphatic and
hematopoietic tissue (four deaths) cancers. Among males,
the rate ratio for all cancer mortality after 20 years (13
deaths) was 1.93 (95 percent CI: 1.12, 3.33); among fe-
males, the rate ratio was 1.17 (95 percent CI: 0.49, 2.83)
based on five cases. The majority of lung cancer deaths in
zone A (all males) occurred after 15 years since the accident,
with 60–70 percent elevated rates (when only males were
considered, the excesses were approximately 90 percent).
No such increases were found in the other zones. In addi-
tion, the lymphatic and hematopoietic tissue cancer excesses
in zone A occurred after 15 years; in zone B, the most
affected categories were 10–14 and 15–19 years. Diabetes
mellitus was elevated in zone B in the first 5 years and in
zone R in the category 10–14 years after the accident; the
excesses were observed among females only. Circulatory
diseases in zone A were elevated mainly in the first 10 years.
Chronic obstructive pulmonary disease mortality was ele-
vated in zone A in the categories 0–4 and 15–19 years and in
zone B in the 5–9–year category.
Among 182 subjects who had developed chloracne soon
after the accident, we found two deaths, one (zone A) from
myocarditis and one from suicide (zone R). No additional
deaths occurred in the 1997–2001 extension. Among resi-
dents of the Polo quarter (located outside zones A and B but
with possible high exposure), we observed no increased
mortality from all causes or all cancers; there were 11 deaths
from lymphatic and hematopoietic cancers (RR ¼ 1.26, 95
percent CI: 0.69, 2.28); and mortality from all circulatory
diseases was modestly elevated (159 deaths, RR ¼ 1.18, 95
percent CI: 1.01, 1.39).
DISCUSSION
In this study, we found elevated mortality from lymphatic
and hematopoietic cancers in the most polluted zones A and
B; there were also suggestions of mortality increases for
several other cancer (rectum, lung) and noncancer (circula-
tory diseases, chronic obstructive pulmonary disease, and
diabetes mellitus) causes. The results for zone B confirmed
previous findings (13, 14). Analysis for zone A alone was,
for the first time, informative because of the increasing
power of the study since follow-up is being continued.
We are confident that the study was not affected by major
selection effects; vital status ascertainment was nearly com-
plete. Limitations exist, the most important one being the
definition of exposure, which could be only categorical,
ecologic, and based on official residence. Some degree of
misclassification was therefore unavoidable for two main
reasons: first, there may have been heterogeneity of expo-
sure to TCDD within each zone; second, residence may not
have been concordant with domicile and/or the effective
presence in the area at the time of the accident and
854 Consonni et al.
Am J Epidemiol 2008;167:847–858
subsequent days or weeks. This nondifferential misclassifi-
cation would tend (on average) to dilute any effect. This
limitation is attenuated by the fact that zone categorization
received support from results on blood dioxin measurements
(41, 43, 44, 47), which clearly indicated that, in general,
there was a definite dose gradient A > B > R and that,
for referents, values were actually in the background range.
Moreover, official residence is highly concordant with do-
micile and was found to be correlated with presence in the
area at the time of the accident in cross-sectional studies
within this same population (41).
The exposed and referent populations belonged to the
same health districts and had similar access to the same
health services; differential death registration patterns are
therefore not expected. The follow-up procedures (tracing
of vital status, collection and coding of causes of death)
were performed blindly with regard to residence of the sub-
jects. This method resulted (table 4) in a distribution of
sources of causes of death fairly balanced across zone. Of
course, the issue remains of some degree of (again, nondif-
ferential) inaccuracy implicit in the use of death certificates.
Although confounding effects cannot be completely ruled
out, their magnitude is expected to be small because of the
use of a local reference population. As part of an earlier
feasibility study, we compared preaccident (1969–1975)
rates from selected causes in the four most versus the seven
less contaminated towns (40): rate ratios were generally
close to the null value or were modestly elevated (RR <
1.25). Exceptions were brain cancer (both genders) and leu-
kemia and liver cirrhosis (females), all of which were not
elevated after the accident.
All cancer mortality was not elevated in the whole period
but showed a 60 percent increase after 20 years in the most
polluted zone A because of elevated mortality among males
only. In this zone, males also showed an elevation in lung
cancer mortality after 15 years of follow-up. These results
are in line with those from studies of highly exposed male
workers (3, 9, 10, 49–55). The lung is also one of the target
organs of the carcinogenic action of TCDD in animals (1, 2).
We did not have individual data on smoking habits; how-
ever, information from independent surveys of random sam-
ples of the population suggests that geographic variation in
smoking habits within the region is low (56, 57). Other in-
direct evidence is provided by the finding that other smok-
ing-related cancers were not elevated.
The rectal cancer excess among males in zone B was
lower than in previous follow-up periods (only one addi-
tional death was observed). For this type of cancer, there
is little experimental evidence of an association with TCDD,
although it has been occasionally found to be elevated in
occupational cohort studies in Germany and New Zealand
(12, 18).
The clearest and most consistent result remains the excess
of lymphatic and hematopoietic neoplasms, which affected
both genders and, in this update, was not limited to zone B
but emerged in zone A as well. The increased pattern for
specific neoplasms was not identical by gender, zone, and
latency, partly because of the small number of deaths. This
finding could hardly be explained by confounding from
known risk factors, and excesses for these neoplasms were
reported in other occupational cohorts (3, 9–12, 18, 49, 53,
54, 58, 59), and the finding is concordant with experimental
studies, which showed a dose-related, increased occurrence
of lymphoma in mice (2, 60). The association with non-
Hodgkin’s lymphomas also gets support from the finding
that, in a sample of residents of the Seveso area, the fre-
quency of cells carrying the t(14;18) translocation (the
most frequent chromosomal translocation in human lym-
phoid malignancies) was positively related to TCDD blood
levels (61).
No deaths from soft-tissue sarcoma, a neoplasm that has
been associated with TCDD exposure (3, 10, 11), were
found in the most polluted zones in 25 years of follow-up.
In addition, no excess was found in zone R.
We found no excess of breast and other gynecologic can-
cers, consistent with previous findings. Recent case-control
studies in selected samples of the Seveso accident popula-
tion suggested a positive association with breast cancer
(62) and a negative one with uterine leiomyomas (63). Other
gender-specific effects recently examined in relation to this
well-established endocrine disruptor (3) were endometriosis
and ovarian function, but no association was found (64, 65).
A weak association with menstrual cycle length and age at
menopause, but not with age at menarche, was found (66–68).
With regard to noncancer causes, we observed excess
mortality from diabetes mellitus among females in all ex-
posure zones, more marked in zone B, but with different
patterns by latency within zones. Although the results might
have been biased by (nondifferential) misclassification (the
diagnostic accuracy of death certificates for this condition is
low), the finding is interesting in light of recent evidence
from a molecular epidemiologic study that identified a reli-
able marker for the diabetogenic action of TCDD (69).
However, the fact that we observed risk excesses among
only females is in contrast with the results of military cohort
studies, which found increased frequency of diabetes and
glucose levels among males (5, 7, 70, 71); controversial
results emerged from occupational settings (17, 19, 72, 73).
Circulatory disease mortality was elevated in zone A in
the early postaccident periods but was lower than expected
in the most recent years. Possible explanations are the direct
toxic role of TCDD itself on cardiac tissue or serum lipids
and/or the tremendously stressful impact of the disaster,
similar to that observed after natural disasters (27, 74, 75).
The increased chronic obstructive pulmonary disease
mortality, especially apparent among zone A males but that
also affected females in zones A and B, substantially reflects
the rate excesses observed in the previous follow-up periods
(no new cases were found in zone A in the latest years). A
plurality of mechanistic considerations can be invoked to
explain this finding, including direct toxicity of TCDD on
bronchiolar/alveolar tissue (1, 2, 76) and interference with
the immune system (77, 78), an effect that has also been
found in a sample of Seveso residents (79), resulting in
impaired protection against repeated lung infections and
progression to chronic disease (80). In a mortality study,
we cannot distinguish between an increase in incidence
and a decrease in the survival of prevalent cases; therefore,
we can also hypothesize, as for heart disease, that accident-
related stressors might have precipitated death among
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people with preexisting disease. The irregular pattern by
latency somewhat stands against these hypotheses, and a re-
sidual confounding effect from smoking remains a possible
explanation.
In conclusion, this study confirmed the excess of lym-
phatic and hematopoietic neoplasms in zone B and added
new evidence of an excess also in the most highly polluted,
although small, zone A. We confirmed rate excesses for
other cancer and noncancer causes, whose interpretation is
curbed for a number of reasons, including the possibility of
some falsely positive associations due to the large number of
comparisons made.
While mortality follow-up is continuing, further insight
into those risks is being sought through molecular epidemi-
ology studies, which demonstrated an interference of TCDD
with gene expression (81–83). The forthcoming update of
the concurrent cancer incidence study (14) is expected to
further contribute to evaluation of the cancer risk to this
population.
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